Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nan Niu
Observed names:
N Niu,
Niu, Nan
Institutions:
Zhejiang Chinese Medical University,
Johns Hopkins University,
Johns Hopkins Medicine,
Zhejiang Provincial Hospital of TCM,
Sidney Kimmel Comprehensive Cancer Center
Observed institutions:
Zhejiang Chinese Medical University,
Johns Hopkins University,
Johns Hopkins Medicine,
Zhejiang Provincial Hospital of TCM,
Zhejiang Provincial People's Hospital,
Sidney Kimmel Comprehensive Cancer Center,
Hangzhou Medical College
show all 7
ORCID:
0000-0002-2360-2384
Observed ORCID:
0000-0002-2360-2384
OpenAlex ID:
A5088277227
A Phase II Study of Allogeneic GM-CSF–Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer
2020
·
Annie A. Wu
, Katherine M. Bever
, et al.
·
Clinical Cancer Research
·
154
CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma
2022
·
Jianxin Wang
, May Tun Saung
, et al.
·
The Journal of Experimental Medicine
·
86
Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses
2022
·
Tao Xia
, Keyu Li
, et al.
·
Journal of Hematology & Oncology
·
84
PDF
Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects
2020
·
Ke‐Yu Li
, Jia‐Long Yuan
, et al.
·
Chronic Diseases and Translational Medicine
·
81
PDF
Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy
2022
·
Alex B. Blair
, Jianxin Wang
, et al.
·
Gastroenterology
·
77
PDF
Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cells
2024
·
Junke Wang
, Jessica Gai
, et al.
·
Science Advances
·
50
Laparoscopic pancreaticoduodenectomy versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic outcomes and long-term survival
2019
·
Ke Chen
, Yucheng Zhou
, et al.
·
Surgical Endoscopy
·
36
Inhibition of focal adhesion kinase enhances antitumor response of radiation therapy in pancreatic cancer through CD8+ T cells
2021
·
Arsen Osipov
, Alex B. Blair
, et al.
·
Cancer Biology and Medicine
·
35
Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model
2022
·
Pan Li
, Noah Rozich
, et al.
·
Cancer Letters
·
33
PDF
Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration
2024
·
Keyu Li
, Junke Wang
, et al.
·
Journal of Hematology & Oncology
·
31
IL35 predicts prognosis in gastric cancer and is associated with angiogenesis by altering TIMP1, PAI1 and IGFBP1
2020
·
Xiao Li
, Nan Niu
, et al.
·
FEBS Open Bio
·
21
PDF
Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer
2025
·
Nan Niu
, Keyu Li
, et al.
·
Biomarker Research
·
10
PDF
Clinical outcome comparison of laparoscopic radical antegrade modular pancreatosplenectomy vs. laparoscopic distal pancreatosplenectomy for left-sided pancreatic ductal adenocarcinoma surgical resection
2022
·
Nan Niu
, Yuhui He
, et al.
·
Frontiers in Surgery
·
6
PDF
Dihydroartemisinin Suppresses LOXL2‐Mediated Glycerophospholipid Metabolic Reprogramming to Induce Cuproptosis in Colorectal Cancer Cells
2025
·
Xing Wei
, Jingfang Wu
, et al.
·
Journal of Biochemical and Molecular Toxicology
·
4
Abstract 6736: Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration
2024
·
Keyu Li
, Junke Wang
, et al.
·
Cancer Research
·
3
KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer
2023
·
Bu, Jiawen
, Zhang, Yixiao
, et al.
·
Figshare
Abstract LB099: Direct identification of MHC class I and class II epitopes for TCR-based T cell therapy for pancreatic cancer
2022
·
Tengyi Zhang
, Jianxin Wang
, et al.
·
Cancer Research
P08.02 CCR2/CCR5 dual-antagonist ‘licenses’ the radiation-induced effector T-cell infiltration in the anti-PD-1 antibody-treated pancreatic adenocarcinoma
2021
·
J Wang
, M Tun Saung
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
P08.01 Rationale of using the combination of anti-PD-1 antibody and anti-IL-8 antibody for the pancreatic cancer treatment
2021
·
P Li
, N Rozich
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Abstract PR-004: Systemic and intratumoral immune profiling in metastatic pancreatic cancer patients who received front-line FOLFIRINOX and were treated with combination immunotherapy with CTLA-4 blockade in the maintenance setting
2020
·
Annie A. Wu
, Katherine M. Bever
, et al.
·
Cancer Research
Show more works
View as search
Works count:
29
Citation count:
711
H-index:
11
I10-index:
12
Year
Topic
Type